Financial Summary (All financials)
| In millions, except per share items | Nov-30-22 | Nov-30-21 | Nov-30-20 | Nov-30-19 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 4,742.9 | 6,141.8 | 3,923.2 | 2,790.1 | 4,077.4 | 10,062.6 | 10,886.5 | 11,486.5 |
| Revenue growth | -22.8% | 56.5% | 40.6% | | -59.5% | -7.6% | -5.2% | 10.2% |
| Cost of goods sold | 3,137.9 | 7,686.6 | 6,322.5 | 2,144.5 | 2,231.9 | 8,581.4 | 9,342.7 | 9,866.0 |
| Gross profit | 1,605.0 | -1,544.8 | -2,399.3 | 645.6 | 1,845.6 | 1,481.2 | 1,543.8 | 1,620.5 |
| Gross margin | 33.8% | -25.2% | -61.2% | 23.1% | 45.3% | 14.7% | 14.2% | 14.1% |
| Selling, general and administrative | 391.5 | 325.5 | 247.1 | | | | | |
| Research and development | 444.0 | 388.1 | 335.1 | | | | | |
| General and administrative | 241.0 | 215.8 | 176.3 | 1,009.6 | 778.1 | 831.9 | 757.8 | 795.9 |
| EBITA | -245.3 | -2,726.1 | -3,514.8 | 624.9 | 722.3 | 490.4 | 543.8 | 487.3 |
| EBITA margin | -5.2% | -44.4% | -89.6% | 22.4% | 17.7% | 4.9% | 5.0% | 4.2% |
| Amortization of intangibles | 10.9 | 14.2 | 15.3 | 14.6 | 12.9 | 63.4 | 63.9 | |
| EBIT | -256.2 | -2,740.3 | -3,530.1 | 610.3 | 709.4 | 427.0 | 479.9 | 487.3 |
| EBIT margin | -5.4% | -44.6% | -90.0% | 21.9% | 17.4% | 4.2% | 4.4% | 4.2% |
| Pre-tax income | 1,055.6 | 2,254.1 | 1,067.1 | 478.6 | 606.5 | 316.4 | 356.5 | 381.2 |
| Income taxes | 273.9 | 576.7 | 298.7 | -484.0 | 642.3 | 122.1 | 109.9 | 166.0 |
| Tax rate | 25.9% | 25.6% | 28.0% | | 105.9% | 38.6% | 30.8% | 43.5% |
| Earnings from continuing ops | 784.1 | 1,673.5 | 773.7 | 960.7 | -39.2 | 192.9 | 241.6 | 431.5 |
| Earnings from discontinued ops | | | | | 288.6 | | 5.5 | -17.9 |
| Net income | 784.1 | 1,673.5 | 773.7 | 960.7 | 249.4 | 192.9 | 247.1 | 413.5 |
| Net margin | 16.5% | 27.2% | 19.7% | 34.4% | 6.1% | 1.9% | 2.3% | 3.6% |
| |
| Diluted EPS | $3.07 | $6.16 | $2.66 | $3.03 | ($0.11) | $0.52 | $0.65 | $1.16 |
| Shares outstanding (diluted) | 255.6 | 271.5 | 290.5 | 317.0 | 370.7 | 371.5 | 372.4 | 373.3 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|